RESOURCES RESOURCES

Diagnosis

A positive chronic hepatitis B diagnosis requires follow-up, from clinical tests to patient education, including:1,2

REFERENCES: 1. Shah HA, Abu-Amara M. Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review. Clin Gastroenterol Hepatol. 2013;11:922-933. 2. Martin P, Lau D, Nguyen M, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update. Clin Gastroenterol Hepatol. 2015;13:2071-2087. 3. Weinbaum CM, Williams I, Mast EE, et al., and The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR08):1-20. 4. Centers for Disease Control and Prevention. Hepatitis B. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine - Preventable Diseases. 13th ed. Washington D.C.: Public Health Foundation;2015:149-174. 5. Kim WR. Epidemiology of hepatitis B in the United States. 2009;49(5 suppl):S28–S34. 6. World Health Organization. Hepatitis B fact sheet. www.who.int/​mediacentre/​factsheets/​fs204/​en/. Updated July 2017. Accessed August 2017. 7. Asian Liver Center at Stanford University. 2013 Physician’s Guide to Hepatitis B: A silent Killer. Palo Alto, CA: Asian Liver Center; 2014. 8. Sarin SK, Kumar M. Epidemiology, screening, and natural history of chronic hepatitis B infection. In: Shetty K, Wu GY, eds. Clinical Gastroenterology: Chronic Viral Hepatitis. Totowa, NJ: Humana Press; 2009:185-241. 9. Tan NC, Cheah, SL. How do general practitioners improve compliance of disease monitoring by patients with chronic hepatitis B infection in primary care? A qualitative study. Asia Pacific Family Medicine. 2004;3:29-37. 10. Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol. 2012;4:43-49. 11. Fattovich G, Bortolotti F, Donato F, et al. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335-352. 12. Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med. 2014;4:a024935. 13. Terrault N, Bzowej NH, Chang KM, et al. AASLD Guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261-283. 14. Tseng TC, Liu CJ, Yang HC, et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2015;64:292-302. 15. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053-2063. 16. Lin CL, Kap JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;28:10-17. 17. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73. 18. Tong MJ, Pan CQ, Hann HW, et al. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56:3143-3162. 19. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:1-36.